L'objectif de ce document de politique est de s'assurer que la diversité est explicitement prise en compte dans la gouvernance du CCTG, ainsi que dans notre participation à d'autres événements que le CCTG pourrait co-organiser ou pour lesquels le CCTG pourrait nommer un représentant (par exemple, un représentant aux réunions organisées par d'autres réseaux/ organismes ou aux réunions / conférences internationales). En outre, cette politique vise à garantir que nos processus sont transparents, visibles et donnent des résultats mesurables.

POUR EN SAVOIR PLUS, téléchargez la politique de diversité du CCCTG (PDF) (anglais).

Le Canadian Critical Care Trials Group (CCCTG) s'engage à offrir un environnement amical, sûr et accueillant pour tous, sans égard au sexe, à l'orientation sexuelle, au handicap, à la race, à l'ethnie, à la religion, à l'origine nationale ou ethnique ou à d'autres caractéristiques (p. ex.) La raison d'être de ce code de conduite est de promouvoir nos valeurs et de veiller à ce que nous restions collégiaux dans nos interactions à l'intérieur et à l'extérieur du CCCTG. Il décrit nos attentes en matière de comportement des participants et les conséquences d'un comportement inacceptable.

POUR EN SAVOIR PLUS, téléchargez la politique du Code de conduite du CCCTG (PDF) (anglais).

Des directives ont été élaborées sur la meilleure façon de faciliter les contributions aux essais cliniques internationaux approuvées par le CCCTG, ainsi que sur la façon de favoriser le soutien international aux initiatives dirigées par des Canadiens. Des critères sont inclus pour l'adoption officielle d'un projet international par le CCCTG.

POUR EN SAVOIR PLUS, téléchargez la Politique d'adoption des projets internationaux du CCCTG (PDF) (anglais). 

Any CCCTG member is welcome to bring protocols to our meetings. This requires pre-circulation of a written protocol to the membership. Before a study is affiliated with the CCCTG name in a grant or publication, the protocol must be discussed at a meeting of the CCCTG, and approved by the membership.

After protocol presentations, revisions are often recommended by the group before grants may be submitted with the affiliation of the Canadian Critical Care Trials Group name. A grant application for funding under the auspices of the CCCTG must be endorsed by the CCCTG Executive Committee prior to its submission. In the latter situation, the Executive in association with one or more members will provide an internal review of the protocol and provide feedback within 2 weeks. The goal of this feedback is provision of constructive comments to investigators about their studies which represent CCCTG membership views on issues of methodology and implementation.

CCCTG authorship must be acknowledged in the grant proposal submitted for funding if all of the following criteria are fulfilled a) the protocol has been presented at a CCCTG meeting, b) support has been given to the project by the CCCTG membership at one of the meetings, c) explicit agreement regarding grant submission was obtained, and d) feedback on the grant itself was provided by the CCCTG Executive. Without these 3 steps, investigators are requested not to make reference to the CCCTG in their proposal.

CCCTG authorship must be acknowledged in all manuscripts submitted for publication if in the opinion of the CCCTG Executive and the investigators, substantial scientific support has been provided by the group at our meetings and between meetings. Without this agreement, investigators are requested not to make reference to the CCCTG in their manuscript.

Before CCCTG authorship is finalized, the CCCTG Executive must review all manuscripts to be submitted to peer-review journals. To allow for (inevitable) last minute preparation, abstracts of CCCTG projects may be submitted to scientific meetings without a priori review by the Executive.

We meet thrice per year, once in January (in Lake Louise), once in May/June (in a rotating location in eastern Canada) and once in October (at the Toronto Critical Care Medicine Symposium).

• Are sponsored by Chair, Exec or any member
• Fund themselves
• Have clear objectives (e.g., starting TG, participating in CCCTG study, not just seeking enrolment in their own study)
• Are invited by Chair in writing (including confidentiality / intellectual property clause)
• Are introduced to CCCTG (background, objectives)
• Address the CCCTG at the end of the meeting (observations, plans for future collaboration)
• Are to limited to 1-2 visitors / meeting

New Studies

• Brief background
• Question/Hypothesis
• Objective(s)
• Design
• Plans (implementation, timelines etc)
• Questions for the CCCTG?

Ongoing Studies

• Brief review of background, question, hypothesis, objective(s), design
• Update
  • Issues raised by group at last meeting
  • Work done since last meeting
  • Milestones
  • Problems
  • Solutions
  • Plans
• Questions for the CCCTG?

• Pre-circulate documents in advance
• Follow presentation guides
• Explain responses to feedback
• Be clear on collaborator commitments
• Provide detailed study update
• Share challenges as well as successes
• Attend each meeting or send representative
• Develop & commit to (revised) timelines
• Ensure study completion

• Read pre-circulated documents in advance
• Provide constructive feedback on rigour, relevance, ethics, feasibility & fundability
• Consider mentorship & partnership
• Problem solve during ongoing trials
• Share tips, study aids & other documents
• Ensure to study completion
• Help to interpret study results
• Review grants & manuscripts within 2 wks

• Provide all necessary study documents
• Provide initial training & ongoing feedback
• Communicate study progress & set-backs
• Advise on local feasibility issues
• Seek advice on study issues
• Follow through on commitments
• Develop & commit to (revised) timelines
• Publish scientific progress
• Ensure study completion

• Understand collaborator commitments
• Problem solve local feasibility issues
• Communicate study progress & set-backs
• Advocate locally for the study
• Follow through on commitments
• Suggest improvements
• Collaborate on scientific progress reports
• Ensure study completion

• Summarize CCCTG feedback
• Write support letters for CCCTG grants
• Advocate for each study across sites
• Help to problem solve
• Ensure the CCCTG honours commitments
• Ensure study completion
• Ensure publication
• Liaise with funding partners as necessary